Abstract
Collagen-induced arthritis (CIA) is a rodent model of human rheumatoid arthritis. Mice of the H-2q (DBA/1J) background are highly susceptible to disease whereas mice of the H-2b (C57BL/6, B6) background are resistant. To determine why B6 mice are resistant to disease induction, we systematically analyzed T and B cell immune responses in B6 mice, compared to DBA/1J mice, following immunization with bovine type II collagen (CII). We found that both strains showed similar T cell proliferation and cytokine responses and similar levels of anti-CII antibodies (Abs) at day 12 or day 14 of initial immunization (primary immune response), however, those B6 mice that did not develop arthritis showed a significant defect in T cell responses and significantly lower levels of anti-CII Abs following secondary boosting immunization (day 35 of initial immunization, secondary immune response) compared to DBA/1J mice. Our results define for the first time that a defective secondary immune responses in B6 mice leads to the resistance of CIA.
Similar content being viewed by others
REFERENCES
Feldmann M, Brennan FM, Maini RN: Rheumatoid arthritis. Cell 85:307–310, 1996
Feldmann M: Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2:364–371, 2002
Feldmann M, Maini RN, Bondeson J, Taylor P, Foxwell BM, Brennan FM: Cytokine blockade in rheumatoid arthritis. Adv Exp Med Biol 490:119–127, 2001
Trentham DE, Townes AS, Kang AH: Autoimmunity to type II col-lagen an experimental model of arthritis. J Exp Med 146:857–868, 1977
Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B: Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283:666–668, 1980
Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, Sakuma S, Ogawa T, Hamaoka T, Senoh H, Fujiwara H: Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Im-munol 140:1477–1484, 1988
Wooley PH, Luthra HS, Stuart JM, David CS: Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 154:688–700, 1981
Ranges GE, Sriram S, Cooper SM: Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med 162:1105–1110, 1985
Yoshino S, Cleland LG, Mayrhofer G: Treatment of collagen-induced arthritis in rats with a monoclonal antibody against the al-pha/ beta T cell antigen receptor. Arthritis Rheum 34:1039–1047, 1991
Wooley PH, Luthra HS, Lafuse WP, Huse A, Stuart JM, David CS: Type II collagen-induced arthritis in mice. III. Suppression of arthri-tis by using monoclonal and polyclonal anti-Ia antisera. J Immunol 134:2366–2374, 1985
Myers LK, Seyer JM, Stuart JM, Terato K, David CS, Kang AH: T cell epitopes of type II collagen that regulate murine collagen-induced arthritis. J Immunol 151:500–505, 1993
Mauri C, Williams RO, Walmsley M, Feldmann M: Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 26:1511–1518, 1996
Svensson L, Jirholt J, Holmdahl R, Jansson L: B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 111:521–526, 1998
Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM: Induction of arthritis with monoclonal antibodies to collagen. J Immunol 148:2103–2108, 1992
Stuart JM, Tomoda K, Yoo TJ, Townes AS, Kang AH: Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum 26:1237–1244, 1983
Stuart JM, Dixon FJ: Serum transfer of collagen-induced arthritis in mice. J Exp Med 158:378–392, 1983
Jirholt J, Cook A, Emahazion T, Sundvall M, Jansson L, Nordquist N, Pettersson U, Holmdahl R: Genetic linkage analysis of collagen-induced arthritis in the mouse. Eur J Immunol 28:3321–3328, 1998
Yang HT, Jirholt J, Svensson L, Sundvall M, Jansson L, Pettersson U, Holmdahl R: Identification of genes controlling collagen-induced arthritis in mice: Striking homology with susceptibility loci previ-ously identified in the rat. J Immunol 163:2916–2921, 1999
McIndoe RA, Bohlman B, Chi E, Schuster E, Lindhardt M, Hood L: Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. Proc Natl Acad Sci USA 96:2210–2214, 1999
Guedez YB, Whittington KB, Clayton JL, Joosten LA, van de Loo FA, van den Berg WB, Rosloniec EF: Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and en-ables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum 44:2413–2424, 2001
Yuasa T, Kubo S, Yoshino T, Ujike A, Matsumura K, Ono M, Ravetch JV, Takai T: Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med 189:187–194, 1999
Wang Y, Kristan J, Hao L, Lenkoski CS, Shen Y, Matis LA: A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol 164:4340–4347, 2000
Yin Z, Zhang DH, Welte T, Bahtiyar G, Jung S, Liu L, Fu XY, Ray A, Craft J: Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: Failure to down-regulate IL-12 receptor beta 2-chain expression. J Immunol 164:3056–3064, 2000
Brand DD, Myers LK, Terato K, Whittington KB, Stuart JM, Kang AH, Rosloniec EF: Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice. J Immunol 152:3088–3097, 1994
Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J: IL-10 regulates murine lupus. J Immunol 169:2148–2155, 2002
Watson WC, Townes AS: Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoanti-body subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med 162:1878–1891, 1985
Luross JA, Williams NA: The genetic and immunopathological pro-cesses underlying collagen-induced arthritis. Immunology 103:407–416, 2001
Miyahara H, Myers LK, Rosloniec EF, Brand DD, Seyer JM, Stuart JM, Kang AH: Identification and characterization of a ma-jor tolerogenic T-cell epitope of type II collagen that suppresses arthritis in B10.RIII mice. Immunology 86:110–115, 1995
Myers LK, Miyahara H, Terato K, Seyer JM, Stuart JM, Kang AH: Collagen-induced arthritis in B10.RIII mice (H-2r): Identification of an arthritogenic T-cell determinant. Immunology 84:509–513, 1995
Tang B, Brand DD, Chiang TM, Stuart JM, Kang AH, Myers LK, Gumanovskaya ML: Immunogenicity and arthritogenicity of recom-binant CB10 in B10.RIII mice. J Immunol 164:481–487, 2000
Martin RM, Brady JL, Lew AM: The need for IgG2c specific an-tiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods 212:187–192, 1998
Martin RM, Silva A, Lew AM: The Igh-1 sequence of the non-obese diabetic (NOD) mouse assigns it to the IgG2c isotype. Immuno-genetics 46:167–168, 1997
Campbell IK, Hamilton JA, Wicks IP: Collagen-induced arthritis in C57BL/6 (H-2b) mice: New insights into an important disease model of rheumatoid arthritis. Eur J Immunol 30:1568–1575, 2000
Ortmann R, Smeltz R, Yap G, Sher A, Shevach EM: A heritable defect in IL-12 signaling in B10.Q/J mice. I. In vitro analysis. J Im-munol 166:5712–5719, 2001
Lanzavecchia A, Sallusto F: Antigen decoding by T lymphocytes: From synapses to fate determination. Nat Immunol 2:487–492, 2001
Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Rein-hardt RL, Itano A, Pape KA: In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 19:23–45, 2001
Yin Z, Siegert S, Neure L, Grolms M, Liu L, Eggens U, Radbruch A, Braun J, Sieper J: The elevated ratio of interferon gamma-/ interleukin-4-positive T cells found in synovial fluid and syn-ovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta. Rheumatology (Oxford) 38:1058–1067, 1999
Simon AK, Seipelt E, Sieper J: Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 91:8562–8566, 1994
Nakae S, Asano M, Horai R, Sakaguchi N, Iwakura Y: IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J Immunol 167:90–97, 2001
Tellander AC, Michaelsson E, Brunmark C, Andersson M: Potent ad-juvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma. J Autoimmun 14:295–302, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pan, M., Kang, I., Craft, J. et al. Resistance to Development of Collagen-Induced Arthritis in C57BL/6 Mice Is Due to a Defect in Secondary, but Not in Primary, Immune Response. J Clin Immunol 24, 481–491 (2004). https://doi.org/10.1023/B:JOCI.0000040919.16739.44
Issue Date:
DOI: https://doi.org/10.1023/B:JOCI.0000040919.16739.44